Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Towards a reliable prognosis for multiple sclerosis].

O Heinzlef1, E Roullet

  • 1Service de neurologie Hôpital Tenon, Paris.

La Revue Du Praticien
|December 22, 1999
PubMed
Summary

Predicting multiple sclerosis prognosis is challenging. Cerebral magnetic resonance imaging (MRI) best predicts conversion to definite multiple sclerosis after a first demyelinating event, aiding in long-term outcome assessment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive interdisciplinary specialized rehabilitation or regular physiotherapy for multiple sclerosis? A randomised controlled trial with economic evaluation.

Annals of physical and rehabilitation medicine·2025
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2015
Same author

[To treat or not to treat asymptomatic bacteriuria before methylprednisolone perfusion].

Revue neurologique·2015
Same author

[Pharmacological treatment of spasticity in multiple sclerosis].

Revue neurologique·2012
Same author

Neuromyelitis optica in France: a multicenter study of 125 patients.

Neurology·2010

Area of Science:

  • Neurology
  • Neuroimmunology
  • Clinical Neuroscience

Context:

  • Multiple sclerosis (MS) prognosis determination in individuals remains difficult despite natural history data.
  • Early identification of disease course is crucial for patient management and therapeutic strategies.
  • The transition from a first demyelinating event to clinically definite MS requires accurate prognostic indicators.

Purpose:

  • To identify key predictors of long-term prognosis in multiple sclerosis.
  • To evaluate the utility of cerebral magnetic resonance imaging (MRI) in predicting MS progression.
  • To outline factors associated with a poor versus benign disease course.

Summary:

  • Cerebral MRI is the strongest predictor of conversion to definite multiple sclerosis following an initial demyelinating episode.
  • Factors indicating a poor long-term prognosis include onset after age 40, initial pyramidal or cerebellar signs, a high relapse rate in the first two years, and early onset of the progressive phase.
  • Approximately 20% of patients experience a benign course of multiple sclerosis.

Impact:

  • Improved individual patient prognostication in multiple sclerosis.
  • Enhanced clinical decision-making for early-stage MS patients.
  • Potential for tailored treatment strategies based on predicted disease trajectory.

Related Experiment Videos